Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1105365 | Transfusion Clinique et Biologique | 2011 | 10 Pages |
Abstract
The improvement measures taken as part of the French haemovigilance declaration framework allowed to perfect the data quality of transfusion transmitted bacterial infection. Progresses are still to be made to improve clinical and biological declaration, in order to precise the accountability of a blood component in the occurrence of an adverse transfusion transmitted bacterial infection effect. Tracking transfusion transmitted bacterial infection notifications by a group of experts at the national level is still recommended.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
A. Delbosc, B. Lafeuillade, R. Petermann, F. Eb, N. Ounnoughene,